News | December 22, 2023
JB Pharma buys opthalmology brands from Novartis for Rs 964 Cr
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
Acetazolamide is used to treat glaucoma
Brimonidine Tartrate Ophthalmic Solution is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
The new facility will be able to handle four times as many patients as the previous facility.
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
The new eye hospital in Vashi is ASG’s second in the Mumbai Metropolitan Region (MMR) and the sixth in Maharashtra
India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved
Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
Subscribe To Our Newsletter & Stay Updated
